NASDAQ:ZYXI Zynex (ZYXI) Stock Price, News & Analysis $8.93 -1.26 (-12.37%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$7.81▼$8.9750-Day Range$8.63▼$10.5852-Week Range$6.88▼$13.77Volume1.03 million shsAverage Volume195,244 shsMarket Capitalization$283.75 millionP/E Ratio38.83Dividend YieldN/APrice Target$14.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Zynex alerts: Email Address Zynex MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside56.8% Upside$14.00 Price TargetShort InterestBearish33.39% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-0.36Based on 18 Articles This WeekInsider TradingN/AProj. Earnings Growth84.31%From $0.51 to $0.94 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.26 out of 5 starsMedical Sector355th out of 936 stocksElectromedical Equipment Industry7th out of 22 stocks 3.5 Analyst's Opinion Consensus RatingZynex has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageZynex has only been the subject of 2 research reports in the past 90 days.Read more about Zynex's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted33.39% of the float of Zynex has been sold short.Short Interest Ratio / Days to CoverZynex has a short interest ratio ("days to cover") of 43.9, which indicates bearish sentiment.Change versus previous monthShort interest in Zynex has recently decreased by 4.22%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldZynex does not currently pay a dividend.Dividend GrowthZynex does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ZYXI. Previous Next 2.0 News and Social Media Coverage News SentimentZynex has a news sentiment score of -0.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 18 news articles for Zynex this week, compared to 2 articles on an average week.Search Interest3 people have searched for ZYXI on MarketBeat in the last 30 days. MarketBeat Follows2 people have added Zynex to their MarketBeat watchlist in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Zynex insiders have not sold or bought any company stock.Percentage Held by Insiders52.13% of the stock of Zynex is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 29.68% of the stock of Zynex is held by institutions.Read more about Zynex's insider trading history. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Zynex are expected to grow by 84.31% in the coming year, from $0.51 to $0.94 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Zynex is 38.83, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 142.60.Price to Earnings Ratio vs. SectorThe P/E ratio of Zynex is 38.83, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 155.18.Price to Book Value per Share RatioZynex has a P/B Ratio of 6.57. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Weiss RatingsNvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.Find out details on these three critical Nvidia partners immediately. About Zynex Stock (NASDAQ:ZYXI)Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and braces for rehabilitation support. Further, it offers Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring and intravascular volume monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.Read More ZYXI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ZYXI Stock News HeadlinesJune 27, 2024 | marketbeat.com7 Short Squeeze Stocks to Look Into for Your PortfolioIn 2021, a trader with a large Reddit following induced a massive rally in shares of GameStop Corp. NYSE: GME. The downtrodden gaming retailer was the most shorted stock in the entire market in January 2021, but the retail buying frenzy triggered a massive run-up in price as hedge funds were forced to cover their short positions to prevent huge losses.July 26 at 4:37 PM | fool.comWhy Zynex Plunged TodayJuly 27, 2024 | Weiss Ratings (Ad)Nvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.July 26 at 11:06 AM | msn.comZynex, Inc. (NASDAQ:ZYXI) Q2 2024 Earnings Call TranscriptJuly 26 at 8:46 AM | investorplace.comWhy Is Zynex (ZYXI) Stock Down 24% Today?July 25 at 10:49 PM | markets.businessinsider.comZYXI Stock Earnings: Zynex Misses EPS, Misses Revenue for Q2 2024July 25 at 7:46 PM | marketwatch.comZynex Shares Drop 18% After 2Q Earnings Miss, Outlook CutJuly 25 at 4:01 PM | prnewswire.comZynex Reports Second Quarter 2024 Financial ResultsJuly 27, 2024 | Weiss Ratings (Ad)Nvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.July 25 at 9:43 AM | markets.businessinsider.comHere's what Wall Street expects from Zynex's earnings reportJuly 24 at 10:41 PM | msn.comZynex Q2 2024 Earnings PreviewJuly 18, 2024 | americanbankingnews.comZynex (NASDAQ:ZYXI) and Pixie Dust Technologies (NASDAQ:PXDT) Critical AnalysisJuly 17, 2024 | prnewswire.comZynex Sets Second Quarter 2024 Earnings CallJuly 11, 2024 | prnewswire.comZynex Recognized as a Best Company to Work For by U.S. News & World Report and Top WorkplacesJune 24, 2024 | investorplace.com3 Short-Squeeze Stocks Poised for a Jaw-Dropping RallyJune 19, 2024 | investorplace.comAnalyst Predictions: 3 Stocks Pegged to Soar Over 40% in One YearJune 10, 2024 | prnewswire.comZynex to Participate in Fireside Chat with RBC Capital Markets on Thursday, June 13, 2024May 10, 2024 | finance.yahoo.comHere's Why We Think Zynex, Inc.'s (NASDAQ:ZYXI) CEO Compensation Looks FairSee More Headlines Receive ZYXI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Zynex and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings7/25/2024Today7/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolNASDAQ:ZYXI CUSIPN/A CIK846475 Webwww.zynex.com Phone(303) 703-4906FaxN/AEmployees1,100Year FoundedN/APrice Target and Rating Average Stock Price Target$14.00 High Stock Price Target$16.00 Low Stock Price Target$12.00 Potential Upside/Downside+101.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)$0.23 Trailing P/E Ratio38.83 Forward P/E Ratio17.51 P/E GrowthN/ANet Income$9.73 million Net Margins4.33% Pretax Margin5.82% Return on Equity16.34% Return on Assets5.76% Debt Debt-to-Equity Ratio1.76 Current Ratio3.58 Quick Ratio2.87 Sales & Book Value Annual Sales$188.68 million Price / Sales1.50 Cash Flow$0.36 per share Price / Cash Flow24.50 Book Value$1.36 per share Price / Book6.57Miscellaneous Outstanding Shares31,775,000Free Float15,211,000Market Cap$283.75 million OptionableOptionable Beta0.53 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. Thomas Sandgaard (Age 65)Founder, President, CEO & Chairman Comp: $992.83kMr. Daniel J. Moorhead (Age 52)Chief Financial Officer Comp: $472.61kMs. Anna Lucsok (Age 37)Chief Operating Officer Comp: $400.84kMr. Steve FoxVice President Of SalesMr. Donald GreggPresident of Zynex Monitoring SolutionsMr. Neil FrieryPresident & COO of Zynex Monitoring Solutions, Inc.More ExecutivesKey CompetitorsBioLife SolutionsNASDAQ:BLFSAxoGenNASDAQ:AXGNSemler ScientificNASDAQ:SMLROutset MedicalNASDAQ:OMEdap TmsNASDAQ:EDAPView All CompetitorsInsiders & InstitutionsBank of New York Mellon CorpBought 2,954 shares on 7/26/2024Ownership: 0.607%Platte River Wealth Advisors LLCBought 20,000 shares on 7/20/2024Ownership: 0.094%Hancock Whitney CorpBought 6,566 shares on 5/17/2024Ownership: 0.104%Walleye Trading LLCSold 4,200 shares on 5/17/2024Ownership: 0.000%Janus Henderson Group PLCSold 76,126 shares on 5/16/2024Ownership: 0.091%View All Insider TransactionsView All Institutional Transactions ZYXI Stock Analysis - Frequently Asked Questions How have ZYXI shares performed this year? Zynex's stock was trading at $10.89 at the beginning of the year. Since then, ZYXI shares have decreased by 18.0% and is now trading at $8.93. View the best growth stocks for 2024 here. How were Zynex's earnings last quarter? Zynex, Inc. (NASDAQ:ZYXI) released its earnings results on Thursday, July, 25th. The company reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.08 by $0.04. The business's revenue was up 11.0% on a year-over-year basis. What is Thomas Sandgaard's approval rating as Zynex's CEO? 81 employees have rated Zynex Chief Executive Officer Thomas Sandgaard on Glassdoor.com. Thomas Sandgaard has an approval rating of 87% among the company's employees. Who are Zynex's major shareholders? Top institutional investors of Zynex include Bank of New York Mellon Corp (0.61%) and Platte River Wealth Advisors LLC (0.09%). Insiders that own company stock include Daniel J Moorhead, Anna Lucsok and Thomas Sandgaard. View institutional ownership trends. How do I buy shares of Zynex? Shares of ZYXI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:ZYXI) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | SponsoredThe asset beating inflation by 4xCentral Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire invest...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zynex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zynex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.